R Patell, L Rybicki, KR McCrae… - American journal of …, 2017 - Wiley Online Library
Inpatient venous thromboembolism (VTE) is a priority preventable illness; risk in cancer varies and prophylaxis is inconsistently used. A previously validated tool (Khorana …
A Chaudhury, A Balakrishnan, C Thai, B Holmstrom… - 2016 - ashpublications.org
BACKGROUND: Venous thromboembolism is a well-known complication of malignancy. The Khorana Risk Score (KRS) utilizes the type of cancer, blood counts, and body mass …
K Austin, J George, EJ Robinson, M Scully… - Journal of …, 2019 - ncbi.nlm.nih.gov
Background Guidelines do not recommend that cancer outpatients receive thromboprophylaxis unless at high venous thromboembolism (VTE) risk, with the Khorana …
FI Mulder, M Candeloro, PW Kamphuisen… - …, 2019 - ncbi.nlm.nih.gov
We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …
N Kucher, D Spirk, I Baumgartner, L Mazzolai, W Korte… - Annals of oncology, 2010 - Elsevier
Background: Venous thromboembolism (VTE) prophylaxis remains underutilized, particularly in cancer patients. We explored clinical predictors of prophylaxis in hospitalized …
Cancer and its treatment are recognized risk factors for VTE. Compliance rate with published VTE prophylaxis guidelines is low. Decision on when to offer prophylaxis for hospitalized …
G Ahmed, HG Nasir, K Hall, L Weissmann - Cureus, 2020 - ncbi.nlm.nih.gov
Introduction: Khorana score (KS) stratifies patients into low, intermediate, and high risk groups for venous thromboembolism (VTE). We examined the generalizability of the KS to …
N van Es, M Ventresca, M Di Nisio… - … of Thrombosis and …, 2020 - Wiley Online Library
Background Oncology guidelines suggest using the Khorana score to select ambulatory cancer patients receiving chemotherapy for primary venous thromboembolism (VTE) …
G Piazza, AF Rao, TN Nguyen… - Clinical and Applied …, 2013 - journals.sagepub.com
Venous thromboembolism (VTE) is a common complication of cancer and chemotherapy. We evaluated the baseline clinical characteristics, thromboprophylaxis patterns, frequency …